A Mouse Model for Human Osteogenesis Imperfecta Type VI

被引:44
|
作者
Bogan, Rosalind [1 ]
Riddle, Ryan C. [1 ,2 ]
Li, Zhu [1 ]
Kumar, Sarvesh [1 ]
Nandal, Anjali [1 ]
Faugere, Marie-Claude [3 ]
Boskey, Adele [4 ]
Crawford, Susan E. [5 ]
Clemens, Thomas L. [1 ,2 ]
机构
[1] Johns Hopkins Univ, Dept Orthopaed Surg, Sch Med, Baltimore, MD 21287 USA
[2] Baltimore Vet Adm Med Ctr, Baltimore, MD USA
[3] Univ Kentucky, Dept Med, Lexington, KY 40506 USA
[4] Hosp Special Surg, Mineralized Tissue Res Lab, New York, NY 10021 USA
[5] St Louis Univ, Dept Pathol, St Louis, MO 63103 USA
关键词
PEDF; OSTEOGENESIS IMPERFECTA; BONE MINERALIZATION; OSTEOBLAST; EPITHELIUM-DERIVED FACTOR; BONE HISTOMORPHOMETRY; PEDF; MUTATIONS; RECEPTOR; NOMENCLATURE; DEFICIENCY; SERPINF1; COLLAGEN; SYMBOLS;
D O I
10.1002/jbmr.1892
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Osteogenesis imperfecta type VI (OI type VI) has recently be linked to a mutation in the SERPINF1 gene, which encodes pigment epithelium-derived factor (PEDF), a ubiquitously expressed protein originally described for its neurotrophic and antiangiogenic properties. In this study, we characterized the skeletal phenotype of a mouse with targeted disruption of Pedf. In normal mouse bone, Pedf was localized to osteoblasts and osteocytes. Micro-computed tomography (mu CT) and quantitative bone histomorphometry in femurs of mature Pedf null mutants revealed reduced trabecular bone volume and the accumulation of unmineralized bone matrix. Fourier transform infrared microscopy (FTIR) indicated an increased mineral:matrix ratio in mutant bones, which were more brittle than controls. In vitro, osteoblasts from Pedf null mice exhibited enhanced mineral deposition as assessed by Alizarin Red staining and an increased mineral:matrix determined by FTIR analysis of calcified nodules. The findings in this mouse model mimic the principal structural and biochemical features of bone observed in humans with OI type VI and consequently provide a useful model with which to further investigate the role of PEDF in this bone disorder.
引用
收藏
页码:1531 / 1536
页数:6
相关论文
共 50 条
  • [31] Strontium Ranelate Reduces the Fracture Incidence in a Growing Mouse Model of Osteogenesis Imperfecta
    Shi, Changgui
    Hu, Bo
    Guo, Lei
    Cao, Peng
    Tian, Ye
    Ma, Jun
    Chen, Yuanyuan
    Wu, Huiqiao
    Hu, Jinquan
    Deng, Lianfu
    Zhang, Ying
    Yuan, Wen
    JOURNAL OF BONE AND MINERAL RESEARCH, 2016, 31 (05) : 1003 - 1014
  • [32] The swaying mouse as a model of osteogenesis imperfecta caused by WNT1 mutations
    Joeng, Kyu Sang
    Lee, Yi-Chien
    Jiang, Ming-Ming
    Bertin, Terry K.
    Chen, Yuqing
    Abraham, Annie M.
    Ding, Hao
    Bi, Xiaohong
    Ambrose, Catherine G.
    Lee, Brendan H.
    HUMAN MOLECULAR GENETICS, 2014, 23 (15) : 4035 - 4042
  • [33] Tendon and motor phenotypes in the Crtap-/- mouse model of recessive osteogenesis imperfecta
    Grol, Matthew William
    Haelterman, Nele A.
    Lim, Joohyun
    Munivez, Elda M.
    Archer, Marilyn
    Hudson, David M.
    Tufa, Sara F.
    Keene, Douglas R.
    Lei, Kevin
    Park, Dongsu
    Kuzawa, Cole D.
    Ambrose, Catherine G.
    Eyre, David R.
    Lee, Brendan H.
    ELIFE, 2021, 10
  • [34] Sclerostin Antibody Improves Skeletal Parameters in a Brtl/+ Mouse Model of Osteogenesis Imperfecta
    Sinder, Benjamin P.
    Eddy, Mary M.
    Ominsky, Michael S.
    Caird, Michelle S.
    Marini, Joan C.
    Kozloff, Kenneth M.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28 (01) : 73 - 80
  • [35] Hypercalcemia and hypercalciuria during denosumab treatment in children with osteogenesis imperfecta type VI
    Trejo, P.
    Rauch, F.
    Ward, L.
    JOURNAL OF MUSCULOSKELETAL & NEURONAL INTERACTIONS, 2018, 18 (01) : 76 - 80
  • [36] Long-term follow-up in osteogenesis imperfecta type VI
    P. Trejo
    T. Palomo
    K. Montpetit
    F. Fassier
    A. Sato
    F. H. Glorieux
    F. Rauch
    Osteoporosis International, 2017, 28 : 2975 - 2983
  • [37] Osteogenesis imperfecta type VI: A form of brittle bone disease with a mineralization defect
    Glorieux, FH
    Ward, LM
    Rauch, F
    Lalic, L
    Roughley, PJ
    Travers, R
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (01) : 30 - 38
  • [38] An unusual presentation of osteogenesis imperfecta type I
    Rebelo, Marta
    Lima, Jandira
    Vieira, Jose Diniz
    Costa, Jose Nascimento
    INTERNATIONAL MEDICAL CASE REPORTS JOURNAL, 2011, 4 : 25 - 29
  • [39] Intravenous Pamidronate in Osteogenesis Imperfecta Type VII
    Cheung, Moira S.
    Glorieux, Francis H.
    Rauch, Frank
    CALCIFIED TISSUE INTERNATIONAL, 2009, 84 (03) : 203 - 209
  • [40] Osteogenesis Imperfecta Type IIA
    Mittal, Aliza
    Sureka, Binit
    Bansal, Neha
    Chellani, Harish
    JOURNAL OF CLINICAL NEONATOLOGY, 2015, 4 (01) : 60 - 61